Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI’s DNBseq™ Technology Platform Partnership marks significant milestone for Natera in monetizing its Signatera MRD test and for BGI Genomics a strong endorsement of its DNBseq™ technology platform by a leader […]
The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set MOUNTAIN VIEW, Calif.–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™ Platform, allowing for easy at-scale navigation and exploration on […]
Non-exclusive collaboration aims to accelerate adoption and ease of use in processing single-tube sample collection version of the market-leading modern blood test for latent TB detection Männedorf, Switzerland, and Germantown, Maryland, Hilden, Germany – The Tecan Group (SIX Swiss Exchange: TECN) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight […]
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing CORALVILLE, IA – As a dedicated innovator of tools and solutions for genomics applications, Integrated DNA Technologies (IDT) introduces its unique, rhAmpSeq™ targeted sequencing system – providing researchers with highly accurate, cost-effective and easy-to-use amplicon sequencing on Illumina® next-generation sequencing (NGS) platforms. The proprietary rhAmpSeq […]
Rijswijk, The Netherlands – BlueBee, a global bioinformatics solutions provider, has been awarded the HDS:2018 certification for its Information Security Management System (ISMS). The Hébergeurs de Données de Santé or Health Data Hosting (HDS) accreditation is required for entities hosting personal health data governed by French laws. The British Standards Institution (BSI) conducted the audit and confirmed […]
Cambridge, Mass. – Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the successful completion of a $135 million Series B financing. Proceeds from the financing will be used to advance the company’s development of next-generation CRISPR technologies, expand its pipeline of base editing programs, and further extend its scientific […]
Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS)… ST. LOUIS — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed […]
March 5, 2019 Boai NKY Medical Holdings Ltd. and Illumina, Inc. will jointly develop novel hereditary disease testing applications utilizing Illumina’s next generation sequencing (NGS) technology. The collaboration is a significant step toward National Medical Products Administration (NMPA) review and approval, and is a starting point to deliver precision medicine products and services to patients throughout […]
Loop Genomics deploys new sequencing technology and protocols to provide unparalleled insight into transcriptome research SAN JOSE, Calif.— Loop Genomics, the single molecule counting long-read sequencing company with a hardware free solution, has expanded its kit and services capabilities to provide researchers with the first solution that provides both transcript counting and phasing for mRNA using […]
TATAA Biocenter Expands its microRNA profiling offering with Somagenics NGS library preparation kits
Göteborg, Sweden – TATAA Biocenter, Europe´s leading provider of genomic services, and SomaGenics, inventor of novel technology for the most efficient NGS library preparation of microRNA, announce collaboration in Europe, where TATAA will be offering exploratory microRNA profiling service and distribution of SomaGenics’s RealSeq® NGS products in Scandinavia, Czech and Slovak Republic. microRNAs are most […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
